Published in Mol Biosyst on November 13, 2012
GIM3E: condition-specific models of cellular metabolism developed from metabolomics and expression data. Bioinformatics (2013) 0.98
The pyruvate-tricarboxylic acid cycle node: a focal point of virulence control in the enteric pathogen Yersinia pseudotuberculosis. J Biol Chem (2014) 0.93
Drug repurposing: a better approach for infectious disease drug discovery? Curr Opin Immunol (2013) 0.86
Coregulation of host-adapted metabolism and virulence by pathogenic yersiniae. Front Cell Infect Microbiol (2014) 0.85
From genome-scale data to models of infectious disease: A Bayesian network-based strategy to drive model development. Math Biosci (2015) 0.80
Omics strategies for revealing Yersinia pestis virulence. Front Cell Infect Microbiol (2012) 0.80
Investigation of Yersinia pestis Laboratory Adaptation through a Combined Genomics and Proteomics Approach. PLoS One (2015) 0.78
Proteomics As a Tool for Studying Bacterial Virulence and Antimicrobial Resistance. Front Microbiol (2016) 0.76
A novel targeted/untargeted GC-Orbitrap metabolomics methodology applied to Candida albicans and Staphylococcus aureus biofilms. Metabolomics (2016) 0.76
Environmental Regulation of Yersinia Pathophysiology. Front Cell Infect Microbiol (2016) 0.75
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Genome sequence of Yersinia pestis, the causative agent of plague. Nature (2001) 14.36
Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS Biol (2007) 10.46
Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol (2003) 6.98
Plasmids in Yersinia pestis. Infect Immun (1981) 6.22
Assembly and function of type III secretory systems. Annu Rev Microbiol (2000) 5.70
Deep sequencing analysis of small noncoding RNA and mRNA targets of the global post-transcriptional regulator, Hfq. PLoS Genet (2008) 5.23
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci U S A (2004) 5.04
Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom Rev (2006) 3.80
FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem (2009) 3.71
DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics (2008) 3.51
The RNA chaperone Hfq is essential for the virulence of Salmonella typhimurium. Mol Microbiol (2006) 3.35
VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics (2007) 3.15
Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science (2002) 3.10
Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev (2004) 3.03
Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis. Genome Res (2003) 2.51
Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses. Anal Chem (2007) 2.38
Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics (2009) 2.36
Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague. Infect Immun (1990) 2.30
Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun (2003) 2.20
MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Anal Chem (2009) 2.17
Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun (2002) 2.16
Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J Bacteriol (2004) 2.04
Robust algorithm for alignment of liquid chromatography-mass spectrometry analyses in an accurate mass and time tag data analysis pipeline. Anal Chem (2006) 1.83
PRISM: a data management system for high-throughput proteomics. Proteomics (2006) 1.80
Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. Infect Immun (1998) 1.76
Yersiniabactin from Yersinia pestis: biochemical characterization of the siderophore and its role in iron transport and regulation. Microbiology (1999) 1.74
Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis (1995) 1.69
MASIC: a software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(/MS) features. Comput Biol Chem (2008) 1.61
Improved peptide elution time prediction for reversed-phase liquid chromatography-MS by incorporating peptide sequence information. Anal Chem (2006) 1.59
Global systems-level analysis of Hfq and SmpB deletion mutants in Salmonella: implications for virulence and global protein translation. PLoS One (2009) 1.58
Plasmid content in Yersinia pestis strains of different origin. FEMS Microbiol Lett (1990) 1.50
The psa locus is responsible for thermoinducible binding of Yersinia pseudotuberculosis to cultured cells. Infect Immun (1996) 1.47
Involvement of the post-transcriptional regulator Hfq in Yersinia pestis virulence. PLoS One (2009) 1.37
Transit through the flea vector induces a pretransmission innate immunity resistance phenotype in Yersinia pestis. PLoS Pathog (2010) 1.36
Reevaluation of the virulence phenotype of the inv yadA double mutants of Yersinia pseudotuberculosis. Infect Immun (1997) 1.36
Physiological basis of the low calcium response in Yersinia pestis. Infect Immun (1994) 1.31
Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice. Int J Med Microbiol (2000) 1.28
The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen. Infect Immun (2004) 1.28
The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis. Infect Immun (2010) 1.25
Array of chemically etched fused-silica emitters for improving the sensitivity and quantitation of electrospray ionization mass spectrometry. Anal Chem (2007) 1.21
Yersiniabactin iron uptake: mechanisms and role in Yersinia pestis pathogenesis. Microbes Infect (2011) 1.19
The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague. Infect Immun (2008) 1.13
Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli. Infect Immun (1999) 1.10
A statistical method for assessing peptide identification confidence in accurate mass and time tag proteomics. Anal Chem (2011) 1.08
Transcriptional regulation in Yersinia: an update. Curr Issues Mol Biol (2005) 1.08
Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis. J Med Microbiol (1995) 1.07
The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PLoS One (2009) 1.01
Evaluation of O-antigen inactivation on Pla activity and virulence of Yersinia pseudotuberculosis harbouring the pPla plasmid. Microbiology (2005) 1.01
Mu dI1(Ap lac) mutagenesis of Yersinia pestis plasmid pFra and identification of temperature-regulated loci associated with virulence. Plasmid (2004) 0.98
Influence of Na(+), dicarboxylic amino acids, and pH in modulating the low-calcium response of Yersinia pestis. Infect Immun (2005) 0.96
The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background. Infect Immun (2010) 0.95
Genetic analysis of virulence determinants unique to Yersinia pestis. Contrib Microbiol Immunol (1995) 0.94
Systems analysis of multiple regulator perturbations allows discovery of virulence factors in Salmonella. BMC Syst Biol (2011) 0.90
Glutamate dehydrogenase and glutamine synthetase are regulated in response to nitrogen availability in Myocbacterium smegmatis. BMC Microbiol (2010) 0.90
Comparative omics-driven genome annotation refinement: application across Yersiniae. PLoS One (2012) 0.86
Formation of dehydroalanine from mimosine and cysteine: artifacts in gas chromatography/mass spectrometry based metabolomics. Rapid Commun Mass Spectrom (2011) 0.85
Optimization of proteomic sample preparation procedures for comprehensive protein characterization of pathogenic systems. J Biomol Tech (2008) 0.81
Multiple-laboratory comparison of microarray platforms. Nat Methods (2005) 11.74
The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature (2003) 10.38
Independence and reproducibility across microarray platforms. Nat Methods (2005) 6.26
Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci U S A (2004) 4.73
Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol (2002) 4.67
The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics (2004) 4.48
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J Proteome Res (2005) 4.13
Advances in proteomics data analysis and display using an accurate mass and time tag approach. Mass Spectrom Rev (2006) 3.80
Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics (2002) 3.57
DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics (2008) 3.51
An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics (2005) 3.51
Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet (2011) 3.23
How much will Herceptin really cost? BMJ (2006) 3.23
Chemically etched open tubular and monolithic emitters for nanoelectrospray ionization mass spectrometry. Anal Chem (2006) 3.22
VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics (2007) 3.15
Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc Natl Acad Sci U S A (2002) 3.15
Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J Proteome Res (2006) 3.10
High-sensitivity ion mobility spectrometry/mass spectrometry using electrodynamic ion funnel interfaces. Anal Chem (2005) 2.99
TLR signaling is required for Salmonella typhimurium virulence. Cell (2011) 2.88
An IMS-IMS analogue of MS-MS. Anal Chem (2006) 2.68
Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation. Genome Res (2007) 2.67
Decon2LS: An open-source software package for automated processing and visualization of high resolution mass spectrometry data. BMC Bioinformatics (2009) 2.65
Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics (2005) 2.50
Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog (2010) 2.48
Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics (2011) 2.44
Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale models. Mol Syst Biol (2010) 2.41
Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. PLoS Pathog (2009) 2.41
Binding MOAD (Mother Of All Databases). Proteins (2005) 2.40
DeconMSn: a software tool for accurate parent ion monoisotopic mass determination for tandem mass spectra. Bioinformatics (2008) 2.38
Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses. Anal Chem (2007) 2.38
Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res (2005) 2.35
Integrative analysis of the mitochondrial proteome in yeast. PLoS Biol (2004) 2.31
Statistical characterization of the charge state and residue dependence of low-energy CID peptide dissociation patterns. Anal Chem (2005) 2.29
High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics (2006) 2.25
High-resolution field asymmetric waveform ion mobility spectrometry using new planar geometry analyzers. Anal Chem (2006) 2.19
Toward plasma proteome profiling with ion mobility-mass spectrometry. J Proteome Res (2006) 2.18
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14
Formation and composition of the Bacillus anthracis endospore. J Bacteriol (2004) 2.12
Transport functions dominate the SAR11 metaproteome at low-nutrient extremes in the Sargasso Sea. ISME J (2008) 2.11
Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics (2006) 2.11
Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics (2008) 2.08
A statistical framework for protein quantitation in bottom-up MS-based proteomics. Bioinformatics (2009) 2.07
Development and evaluation of a micro- and nanoscale proteomic sample preparation method. J Proteome Res (2005) 2.06
Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids. Infect Immun (2003) 2.05
The genome of Cyanothece 51142, a unicellular diazotrophic cyanobacterium important in the marine nitrogen cycle. Proc Natl Acad Sci U S A (2008) 2.05
Ionization and transmission efficiency in an electrospray ionization-mass spectrometry interface. J Am Soc Mass Spectrom (2007) 2.03
Fundamentals of traveling wave ion mobility spectrometry. Anal Chem (2008) 2.02
Biological removal of polychlorinated dibenzo-p-dioxins from incinerator fly ash by Sphingomonas wittichii RW1. Water Res (2005) 2.02
Clinical microfluidics for neutrophil genomics and proteomics. Nat Med (2010) 2.02
Use of artificial neural networks for the accurate prediction of peptide liquid chromatography elution times in proteome analyses. Anal Chem (2003) 2.00
Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal Chem (2004) 2.00
High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology. Anal Chem (2004) 1.99
Binding MOAD, a high-quality protein-ligand database. Nucleic Acids Res (2007) 1.99
Head-to-head comparison of serum fractionation techniques. J Proteome Res (2007) 1.98
Clustering millions of tandem mass spectra. J Proteome Res (2007) 1.98
Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res (2005) 1.96
Spectral archives: extending spectral libraries to analyze both identified and unidentified spectra. Nat Methods (2011) 1.95
Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics (2005) 1.94
High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol Cell Proteomics (2004) 1.94
Global profiling of Shewanella oneidensis MR-1: expression of hypothetical genes and improved functional annotations. Proc Natl Acad Sci U S A (2005) 1.93
Ion mobility spectrometry-mass spectrometry performance using electrodynamic ion funnels and elevated drift gas pressures. J Am Soc Mass Spectrom (2007) 1.93
Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment. J Proteome Res (2006) 1.93
Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom Rev (2005) 1.91
Peptide alarmone signalling triggers an auto-active bacteriocin necessary for genetic competence. Mol Microbiol (2009) 1.91
Ion funnel trap interface for orthogonal time-of-flight mass spectrometry. Anal Chem (2007) 1.88
High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Anal Chem (2002) 1.88
Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics. Anal Chem (2005) 1.87
Precautionary behavior in response to perceived threat of pandemic influenza. Emerg Infect Dis (2007) 1.84
Robust algorithm for alignment of liquid chromatography-mass spectrometry analyses in an accurate mass and time tag data analysis pipeline. Anal Chem (2006) 1.83
Analysis of the Salmonella typhimurium proteome through environmental response toward infectious conditions. Mol Cell Proteomics (2006) 1.82
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology (2012) 1.82
Improving mass spectrometer sensitivity using a high-pressure electrodynamic ion funnel interface. J Am Soc Mass Spectrom (2006) 1.80
Analysis of Deinococcus radiodurans's transcriptional response to ionizing radiation and desiccation reveals novel proteins that contribute to extreme radioresistance. Genetics (2004) 1.80
Proteomic analyses using an accurate mass and time tag strategy. Biotechniques (2004) 1.80
PRISM: a data management system for high-throughput proteomics. Proteomics (2006) 1.80
Does trypsin cut before proline? J Proteome Res (2007) 1.79
Enhanced ion utilization efficiency using an electrodynamic ion funnel trap as an injection mechanism for ion mobility spectrometry. Anal Chem (2008) 1.79
Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc Natl Acad Sci U S A (2012) 1.75
Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin. J Bacteriol (2006) 1.73
Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics (2006) 1.73